Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Home Visits and Telephone-Supported Education for Adults With Type 2 Diabetes

15. november 2026 oppdatert av: Saglik Bilimleri Universitesi

Effects of Home Visits and Telephone-Supported Educational Interventions on Diabetes Knowledge, Self-Care Behaviors, and Diabetes-Related Difficulties in Individuals With Type 2 Diabetes Attending a Family Health Center

This study aims to evaluate the effects of home visits and telephone-supported education on diabetes knowledge, self-care behaviors, and diabetes-related difficulties in adults with type 2 diabetes attending a family health center in Türkiye. The study will examine whether these educational approaches help participants better understand their diabetes, manage daily self-care, and cope with difficulties related to living with diabetes.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

90

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Istanbul
      • Istanbul, Istanbul, Tyrkia (Türkiye), 34035
        • Rekruttering
        • Şehit İbrahim Ceylan Aile Sağlığı Merkezi
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

Aged 18-65 years. Diagnosed with type 2 diabetes mellitus for at least 6 months. Able to read and understand Turkish. No health condition that impairs cognition or communication. Owns a smartphone. Uses insulin, oral antidiabetic medication, or both. Willing to participate in the study.

Exclusion Criteria:

Pregnancy. Inability to complete the data collection instruments due to a cognitive or psychiatric condition.

Unwillingness to participate in the study.

-

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Home Visit-Based Education

Participants in this group will receive nurse-led diabetes education through home visits. The education will focus on diabetes knowledge, daily self-care behaviors, and coping with diabetes-related difficulties.

A nurse will provide four structured, face-to-face diabetes education sessions in participants' homes, once weekly for four weeks. Each visit will last approximately 45-60 minutes and use PowerPoint presentations, informational brochures, direct instruction, and questions and answers. Weekly topics will cover: (1) diabetes, symptoms, risk factors, complications, hypoglycemia, hyperglycemia, and regular health checks; (2) nutrition, carbohydrate management, food label reading, portion control, and physical activity; (3) medication adherence, insulin use, blood glucose monitoring, foot care, oral care, sleep, and screening; and (4) diabetes-related difficulties, stress management, problem-solving, social support, personal strengths, goal setting, and behavior change.

Eksperimentell: Telephone-Supported Education

Participants in this group will receive nurse-led, telephone-supported diabetes education. The education will focus on diabetes knowledge, daily self-care behaviors, and coping with diabetes-related difficulties.

A nurse will provide four structured tele-nursing sessions over one month, once weekly, using telephone calls, video calls, and digital educational materials, including PowerPoint presentations and brochures. Each session will last approximately 15-25 minutes, with additional counseling time when needed. The educational content will be similar to that provided to the home visit group. Weekly topics will cover: (1) diabetes, symptoms, risk factors, complications, hypoglycemia, hyperglycemia, and regular health checks; (2) nutrition, carbohydrate management, food label reading, portion control, and physical activity; (3) medication adherence, insulin use, blood glucose monitoring, foot care, oral care, sleep, and screening; and (4) diabetes-related difficulties, stress management, problem-solving, social support, personal strengths, goal setting, and behavior change. Sessions will reinforce learning, support motivation, and address individual self-care needs.

Ingen inngripen: Usual Care Control Group

Participants in this group will continue to receive usual care at the family health center. They will not receive the study-specific home visit-based or telephone-supported educational interventions during the study period.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Diabetes Health-Promoting Self-Care Behaviors
Tidsramme: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.

Changes in self-care behaviors will be assessed using the Turkish version of the Diabetes Health-Promoting Self-Care Scale. The scale includes 27 items across seven domains: interpersonal relationships, personal health responsibility, diet, exercise, foot care, blood glucose self-monitoring, and adherence to the recommended regimen. Each item is scored from 1 to 5, giving a total score of 27-135. Higher scores indicate better health-promoting self-care behaviors.

Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
Change in Diabetes Knowledge
Tidsramme: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.

Changes in diabetes knowledge will be assessed using the 28-item Adult Diabetes Knowledge Scale developed by Yavuz and Erol. Each correct answer receives 1 point; incorrect and "I do not know" responses receive 0 points. Total scores range from 0 to 28, with higher scores indicating greater diabetes knowledge.

Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
Change in Diabetes-Related Difficulties
Tidsramme: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.

Changes in diabetes-related difficulties will be assessed using the 30-item Type 2 Diabetes Strengths and Difficulties Scale developed by Bilgehan and Inkaya. The scale assesses difficulties related to lack of knowledge, individual difficulties, and psychosocial difficulties. Each item is scored from 1 (never experience difficulty) to 5 (always experience difficulty), giving a total score of 30-150. Higher scores indicate greater diabetes-related difficulties.

Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

10. november 2026

Primær fullføring (Antatt)

31. mars 2027

Studiet fullført (Antatt)

31. mars 2027

Datoer for studieregistrering

Først innsendt

15. november 2026

Først innsendt som oppfylte QC-kriteriene

15. november 2026

Først lagt ut (Faktiske)

19. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

19. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

15. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

There is currently no plan to share individual participant data with other researchers.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere